Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.
- Authors
- Sullivan, P F; de Geus, E J C; Willemsen, G; James, M R; Smit, J H; Zandbelt, T; Arolt, V; Baune, B T; Blackwood, D; Cichon, S; Coventry, W L; Domschke, K; Farmer, A; Fava, M; Gordon, S D; He, Q; Heath, A C; Heutink, P; Holsboer, F; Hoogendijk, W J; Hottenga, J J; Hu, Y; Kohli, M; Lin, D; Lucae, S; Macintyre, D J; Maier, W; McGhee, K A; McGuffin, P; Montgomery, G W; Muir, W J; Nolen, W A; Nöthen, M M; Perlis, R H; Pirlo, K; Posthuma, D; Rietschel, M; Rizzu, P; Schosser, A; Smit, A B; Smoller, J W; Tzeng, J-Y; van Dyck, R; Verhage, M; Zitman, F G; Martin, N G; Wray, N R; Boomsma, D I; Penninx, B W J H
- Year
- 2009
- Journal
- Molecular psychiatry
- PMID
- 19065144
- DOI
- 10.1038/mp.2008.125
- PMCID
- PMC2717726
Major depressive disorder (MDD) is a common complex trait with enormous public health significance. As part of the Genetic Association Information Network initiative of the US Foundation for the National Institutes of Health, we conducted a genome-wide association study of 435 291 single nucleotide polymorphisms (SNPs) genotyped in 1738 MDD cases and 1802 controls selected to be at low liability for MDD. Of the top 200, 11 signals localized to a 167 kb region overlapping the gene piccolo (PCLO, whose protein product localizes to the cytomatrix of the presynaptic active zone and is important in monoaminergic neurotransmission in the brain) with P-values of 7.7 x 10(-7) for rs2715148 and 1.2 x 10(-6) for rs2522833. We undertook replication of SNPs in this region in five independent samples (6079 MDD independent cases and 5893 controls) but no SNP exceeded the replication significance threshold when all replication samples were analyzed together. However, there was heterogeneity in the replication samples, and secondary analysis of the original sample with the sample of greatest similarity yielded P=6.4 x 10(-8) for the nonsynonymous SNP rs2522833 that gives rise to a serine to alanine substitution near a C2 calcium-binding domain of the PCLO protein. With the integrated replication effort, we present a specific hypothesis for further studies.
GWAS results for MDD in cases versus controls. Panel a shows the quantile-quantile plots and lambda estimates for the primary analysis using the Cochran-Armitage trend test and confirmatory analyses using logistic regressions and Cochran-Mantel-Haenszel stratified tests. The dashed lines show the expected 95% probability interval for ordered p-values, and the circles show the observed versus expected values for all SNPs. The λ values are the median Χ2 from all association tests divided by the expected value under the null hypothesis of no association. If λ is large (e.g., >1.2), there is evidence that the observed test statistics deviate from the expected. This could be due to true associations but is more likely due to a systematic bias (e.g., population stratification effects). The λ values in Panel a are not consistent with the presence of stematic biases in the results. Panel b depicts −log10(p) by genomic location for chr1-chr22 plus chrX. Odd-numbered chromosomes are in light blue and even-numbered chromosomes in orange. The 25 smallest p-values are shown with green crosses.
Plot of the PCLO region (NCBI build 35, UCSC hg17, chr7:82,000,000-82,500,000). P-values in this figure are all from SNPMstat. The x-axis is chromosomal position, the left y-axis −log10(p) for genotyped SNPs (colored diamonds) and imputed SNPs (grey diamonds), and the right y-axis the recombination rate from the HapMap EUR panel (light blue curve). The color of the genotyped SNPs corresponds to LD with the SNP with smallest p-value (rs2715148): red 0.8 ≤ r2 ≤ 1.0, orange 0.5 ≤ r2 < 0.8, yellow 0.2 ≤ r2 < 0.5, and white r2 < 0.2. The significant and extent of all 3-SNP haplotypes with p<0.0001 in this region are colored light green. The transcripts for two PCLO isoforms are shown in dark green at the bottom. Graph adapted from an R function by the Broad DGI group.
PCLO region replication results for MDD showing genomic context and forest plots for the top 12 SNPs in the original sample. The backbone of the graph is the region of PCLO targeted for follow-up. SNP locations are given by the grey triangles. There are 12 forest plots for the SNPs with p<0.001 in the original sample. Each forest plot is for one SNP and shows the odds ratio (square) and 95% confidence intervals (horizontal line) for a particular sample with the area of the square proportional to sample size.
| Name | Type |
|---|---|
| ADHD | phenotype |
| ANK3 | gene |
| anxiety | phenotype |
| ARIADNE local | cohort |
| autism | phenotype |
| AutoGenFlex 3000 workstation local | drug |
| bipolar disorder | phenotype |
| Bipolar GWAS (DNA pooling) local | cohort |
| brain | anatomy |
| CACNA1C | gene |
| CALD1 local | gene |
| case/control status | phenotype |
| cases | cohort |
| cerebellum | anatomy |
| CFLAR local | gene |
| CNV | variant |
| community | cohort |
| controls | cohort |
| copy number variation | variant |
| DAOA | gene |
| dbGaP | cohort |
| depressive symptoms | phenotype |
| Dgkh | gene |
| diagnostic criteria | phenotype |
| disorder | phenotype |
| Dmd | gene |
| DRD2 | gene |
| Drug/alcohol dependence local | phenotype |
| Dutch samples local | cohort |
| Dutch subjects local | cohort |
| educational attainment | phenotype |
| EEF1A1 | gene |
| EUR control group local | cohort |
| European ancestry | cohort |
| final analysis dataset local | cohort |
| FlexiGene DNA AGF3000 kit local | drug |
| FMR2 | gene |
| frontal cortex | anatomy |
| GAIN | cohort |
| GAIN initiative | cohort |
| GAIN-MDD study local | cohort |
| General practice local | cohort |
| Genetic Association Information Network (GAIN) local | cohort |
| German sample | cohort |
| GRM7 | gene |
| GWAS | cohort |
| HapMap | cohort |
| HapMap2 EUR panel local | cohort |
| HapMap Asian panel local | cohort |
| HapMap CEU | cohort |
| HapMap European panel local | cohort |
| HapMap EUR panel local | cohort |
| HapMap internal control samples local | cohort |
| Hemizygous SNPs (non-PAR chrX and chrY) local | variant |
| Heterozygous SNPs (chr1-22 and chrX/PAR1) local | variant |
| Heterozygous SNPs (non-PAR chrX) local | variant |
| HLA-B | gene |
| ITIH1 | gene |
| Klinefelter's syndrome local | phenotype |
| Low genetic liability for MDD local | phenotype |
| LST1 local | gene |
| major depressive disorder | phenotype |
| MAMDC1 | gene |
| MARCH3 local | gene |
| MDD cases local | phenotype |
| MDD controls local | phenotype |
| mood disorders | phenotype |
| NEMESIS local | cohort |
| NESDA | cohort |
| NESDA/NTR GWAS local | cohort |
| NESDA/NTR sample local | cohort |
| Netherlands Twin Register | cohort |
| neuroticism | phenotype |
| non-European ancestry | cohort |
| non-SNP genetic variation local | variant |
| Normal sadness local | phenotype |
| Nos1 | gene |
| NTR | cohort |
| original sample local | cohort |
| PCLO | gene |
| PCLO C2A domain SNP local | variant |
| PCLO SNPs local | variant |
| Perlegen local | cohort |
| Perlegen local | drug |
| PicoGreen dsDNA Quantitation kit local | drug |
| positive selection | phenotype |
| presynaptic active zone local | anatomy |
| primary care | cohort |
| psychiatric disorders | phenotype |
| Psychiatric Genomics Consortium | cohort |
| PTCHD1 | gene |
| Puregene DNA isolation kit local | drug |
| QIMR | cohort |
| Quanto local | drug |
| reoMDD local | phenotype |
| rs10521594 local | variant |
| rs10954694 local | variant |
| rs11094388 local | variant |
| rs2207796 local | variant |
| rs2522833 | variant |
| rs2715148 local | variant |
| rs4618863 local | variant |
| rs4839627 local | variant |
| rs5930667 local | variant |
| rs5936428 local | variant |
| rs5971108 local | variant |
| sex | phenotype |
| SGCG | gene |
| SHFM1 local | gene |
| SLC9A9 | gene |
| smoking | phenotype |
| SNP | cohort |
| Somatic diseases local | phenotype |
| Stanley Foundation local | cohort |
| suicide | phenotype |
| Tertiary Care local | cohort |
| Top 25 multi-SNP clusters local | variant |
| top SNPs | cohort |
| TP73L local | gene |
| Turner's syndrome local | phenotype |
| type 2 diabetes | phenotype |
| UGT2B4 local | gene |
| US Foundation for the NIH local | cohort |
| women | cohort |
| WTCCC GWAS local | cohort |
| ZNF804A | gene |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms. | Chen X et al. | — | 2025 | → |
| Prevalence of metabolic syndrome in Chinese patients with schizophrenia: a systematic review and meta-analysis. | Feng L et al. | — | 2025 | → |
| An overview of major depression disorder: The endocannabinoid system as a potential target for therapy. | Zarazúa-Guzmán S et al. | — | 2024 | → |
| Classification of Schizophrenia, Bipolar Disorder and Major Depressive Disorder with Comorbid Traits and Deep Learning Algorithms | Chen X et al. | — | 2024 | — |
| Effects of Early Stress Exposure on Anxiety-like Behavior and <i>MORC1</i> Expression in Rats. | Mundorf A et al. | — | 2024 | → |
| Examining the Effect of Genes on Depression as Mediated by Smoking and Modified by Sex. | Voorhies K et al. | — | 2024 | → |
| Expanding the Phenotype of the CACNA1C-Associated Neurological Disorders in Children: Systematic Literature Review and Description of a Novel Mutation. | Cipriano L et al. | — | 2024 | → |
| CACNA1C-Related Channelopathies. | Herold KG et al. | — | 2023 | → |
| Correlation between variants of the CREB1 and GRM7 genes and risk of depression. | Wang L et al. | — | 2023 | → |
| DNA methylation and general psychopathology in childhood: an epigenome-wide meta-analysis from the PACE consortium. | Rijlaarsdam J et al. | — | 2023 | → |
| Dysfunction of GluN3A subunit is involved in depression-like behaviors through synaptic deficits. | Zhang M et al. | — | 2023 | → |
| Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers. | Singh P et al. | — | 2023 | → |
| Reduced Vrk2 expression is associated with higher risk of depression in humans and mediates depressive-like behaviors in mice. | Yin MY et al. | — | 2023 | → |
| Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations. | Liu D et al. | — | 2023 | → |
| Sex differences in sleep quality and psychological distress: Insights from a middle-aged twin sample from Spain. | Madrid-Valero JJ et al. | — | 2023 | → |
| The genetic basis of major depressive disorder. | Flint J | — | 2023 | → |
| Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals. | Anguita-Ruiz A et al. | — | 2022 | → |
| Characterization of <i>PCLO</i> Gene in Amazonian Native American Populations. | Cohen-Paes AN et al. | — | 2022 | → |
| Identification of a Novel Functional Non-synonymous Single Nucleotide Polymorphism in Frizzled Class Receptor 6 Gene for Involvement in Depressive Symptoms. | Han H et al. | — | 2022 | → |
| Knockdown of Piccolo in the Nucleus Accumbens Suppresses Methamphetamine-Induced Hyperlocomotion and Conditioned Place Preference in Mice. | Kusui Y et al. | — | 2022 | → |
| Local dynamic spontaneous brain activity changes in first-episode, treatment-naïve patients with major depressive disorder and their associated gene expression profiles. | Xue K et al. | — | 2022 | → |
| Molecular mechanisms of synaptogenesis. | Qi C et al. | — | 2022 | → |
| Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder. | Grant CW et al. | — | 2022 | → |
| Schizophrenia Outside the Brain. | Valença AGF et al. | — | 2022 | → |
| The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder. | Mohammad GS et al. | — | 2022 | → |
| Understanding Anhedonia from a Genomic Perspective. | Bondy E et al. | — | 2022 | → |
| Analysis of Major Depression Risk Genes Reveals Evolutionary Conservation, Shared Phenotypes, and Extensive Genetic Interactions. | Sall S et al. | — | 2021 | → |
| Cohort profile of the longitudinal Netherlands Study of Depression and Anxiety (NESDA) on etiology, course and consequences of depressive and anxiety disorders. | Penninx BWJH et al. | — | 2021 | → |
| Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients. | Lang X et al. | — | 2021 | → |
| DNA methylation in stress and depression: from biomarker to therapeutics. | Sales AJ et al. | — | 2021 | → |
| DNA methylation of the KLK8 gene in depression symptomatology. | Starnawska A et al. | — | 2021 | → |
| Fifteen years of NESDA Neuroimaging: An overview of results related to clinical profile and bio-social risk factors of major depressive disorder and common anxiety disorders. | van Tol MJ et al. | — | 2021 | → |
| Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression. | Hu G et al. | — | 2021 | → |
| Grey matter volume abnormalities in the first depressive episode of medication-naïve adult individuals: a systematic review of voxel based morphometric studies. | Amidfar M et al. | — | 2021 | → |
| Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes <i>BSN</i> and <i>PCLO</i> in Schizophrenia and Bipolar Disorder. | Chen CH et al. | — | 2021 | → |
| Identifying a novel biological mechanism for alcohol addiction associated with circRNA networks acting as potential miRNA sponges. | Vornholt E et al. | — | 2021 | → |
| Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications. | Li Z et al. | — | 2021 | → |
| Measurement and genetic architecture of lifetime depression in the Netherlands as assessed by LIDAS (Lifetime Depression Assessment Self-report). | Fedko IO et al. | — | 2021 | → |
| MORC1 methylation and BDI are associated with microstructural features of the hippocampus and medial prefrontal cortex. | Mundorf A et al. | — | 2021 | → |
| Nuclear receptors modulate inflammasomes in the pathophysiology and treatment of major depressive disorder. | Wang H et al. | — | 2021 | → |
| Probing Synaptic Signaling with Optogenetic Stimulation and Genetically Encoded Calcium Reporters. | Borja GB et al. | — | 2021 | → |
| Repeated episodes of transient reduction of oxygen exposure simulating aircraft cabin conditions enhance resilience to stress in mice. | Ginerete RP et al. | — | 2021 | → |
| Schizophrenia-Like Behavioral Impairments in Mice with Suppressed Expression of Piccolo in the Medial Prefrontal Cortex. | Nitta A et al. | — | 2021 | → |
| Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia. | Zhou Y et al. | — | 2021 | → |
| Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population. | Li Z et al. | — | 2021 | → |
| The genetic basis of major depression. | Kendall KM et al. | — | 2021 | → |
| The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia. | Lang X et al. | — | 2021 | → |
| Genetics of resilience: Implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression. | Maul S et al. | — | 2020 | → |
| Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples. | Aberg KA et al. | — | 2020 | → |
| Sex differences in the genetic architecture of depression. | Kang HJ et al. | — | 2020 | → |
| Systemic neuro-dysregulation in depression: Evidence from genome-wide association. | Tubbs JD et al. | — | 2020 | → |
| Critical role for Piccolo in synaptic vesicle retrieval. | Ackermann F et al. | — | 2019 | → |
| Epigenome-wide association study of depression symptomatology in elderly monozygotic twins. | Starnawska A et al. | — | 2019 | → |
| Genetic variants in major depressive disorder: From pathophysiology to therapy. | Gonda X et al. | — | 2019 | → |
| Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder. | Noroozi R et al. | — | 2019 | → |
| GWAS of Behavioral Traits. | Mehta D et al. | — | 2019 | → |
| Network Analysis of Depression-Related Transcriptomic Profiles. | Miao X et al. | — | 2019 | → |
| Nitric oxide signalling and antidepressant action revisited. | Joca SRL et al. | — | 2019 | → |
| Novel susceptibility genes were found in a targeted sequencing of stroke patients with or without depression in the Chinese Han population. | Fuying Z et al. | — | 2019 | → |
| Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk. | Srivastava A et al. | — | 2019 | → |
| Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics. | Liu D et al. | — | 2018 | → |
| Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition. | Lang D et al. | — | 2018 | → |
| Differentially expressed genes related to major depressive disorder and antidepressant response: genome-wide gene expression analysis. | Woo HI et al. | — | 2018 | → |
| Family History as an Important Factor for Stratifying Participants in Genetic Studies of Major Depression. | Zalar B et al. | — | 2018 | → |
| Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP). | Ren H et al. | — | 2018 | → |
| Genetics Factors in Major Depression Disease. | Shadrina M et al. | — | 2018 | → |
| Menin Deficiency Leads to Depressive-like Behaviors in Mice by Modulating Astrocyte-Mediated Neuroinflammation. | Leng L et al. | — | 2018 | → |
| Molecular genetic overlap between migraine and major depressive disorder. | Yang Y et al. | — | 2018 | → |
| TPH2 polymorphisms across the spectrum of psychiatric morbidity: A systematic review and meta-analysis. | Ottenhof KW et al. | — | 2018 | → |
| A continuum of genetic liability for minor and major depression. | Corfield EC et al. | — | 2017 | → |
| An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype. | Direk N et al. | — | 2017 | → |
| Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders. | Torres VI et al. | — | 2017 | → |
| Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist. | Martin J et al. | — | 2017 | → |
| Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. | Power RA et al. | — | 2017 | → |
| Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. | Witt SH et al. | — | 2017 | → |
| Genome-wide haplotype-based association analysis of major depressive disorder in Generation Scotland and UK Biobank. | Howard DM et al. | — | 2017 | → |
| Genome-Wide Significance for PCLO as a Gene for Major Depressive Disorder. | Mbarek H et al. | — | 2017 | → |
| Intergenic variants may predispose to major depression disorder through regulation of long non-coding RNA expression. | Ye N et al. | — | 2017 | → |
| Noncoding RNAs in Depression. | Lin R et al. | — | 2017 | → |
| PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder. | Igata R et al. | — | 2017 | → |
| Proteomic analysis of sockeye salmon serum as a tool for biomarker discovery and new insight into the sublethal toxicity of diluted bitumen. | Alderman SL et al. | — | 2017 | → |
| Systematic review and meta-analysis of genetic studies of late-life depression. | Tsang RS et al. | — | 2017 | → |
| The association of childhood maltreatment with depression and anxiety is not moderated by the oxytocin receptor gene. | Tollenaar MS et al. | — | 2017 | → |
| The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder. | Mandelli L et al. | — | 2017 | → |
| The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders. | Ou J et al. | — | 2017 | → |
| Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis. | Rao S et al. | — | 2016 | → |
| Gene expression in major depressive disorder. | Jansen R et al. | — | 2016 | → |
| Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression. | Knowles EE et al. | — | 2016 | → |
| Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: the role of gender. | Klein M et al. | — | 2016 | → |
| Polygenic dissection of major depression clinical heterogeneity. | Milaneschi Y et al. | — | 2016 | → |
| Recurrent major depression and right hippocampal volume: A bivariate linkage and association study. | Mathias SR et al. | — | 2016 | → |
| Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies. | Demirkan A et al. | — | 2016 | → |
| Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor. | de Kloet ER et al. | — | 2016 | → |
| Systems biology integration of proteomic data in rodent models of depression reveals involvement of the immune response and glutamatergic signaling. | Carboni L et al. | — | 2016 | → |
| The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population. | Otowa T et al. | — | 2016 | → |
| The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders. | Smoller JW | — | 2016 | → |
| Advances in imaging ultrastructure yield new insights into presynaptic biology. | Bruckner JJ et al. | — | 2015 | → |
| Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses. | Jentsch MC et al. | — | 2015 | → |
| Comparative genome-wide association studies of a depressive symptom phenotype in a repeated measures setting by race/ethnicity in the Multi-Ethnic Study of Atherosclerosis. | Ware EB et al. | — | 2015 | → |
| DISC1 gene and affective psychopathology: a combined structural and functional MRI study. | Opmeer EM et al. | — | 2015 | → |
| Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression. | Ching-López A et al. | — | 2015 | → |
| Explore the Features of Brain-Derived Neurotrophic Factor in Mood Disorders. | Yeh FC et al. | — | 2015 | → |
| Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. | Ferentinos P et al. | — | 2015 | → |
| FRAS1-related extracellular matrix 3 (FREM3) single-nucleotide polymorphism effects on gene expression, amygdala reactivity and perceptual processing speed: An accelerated aging pathway of depression risk. | Nikolova YS et al. | — | 2015 | → |
| Functional characterization of the PCLO p.Ser4814Ala variant associated with major depressive disorder reveals cellular but not behavioral differences. | Giniatullina A et al. | — | 2015 | → |
| Gene-environment interaction in major depression: focus on experience-dependent biological systems. | Lopizzo N et al. | — | 2015 | → |
| Genetic determinants of depression: recent findings and future directions. | Dunn EC et al. | — | 2015 | → |
| Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability. | Vergult S et al. | — | 2015 | → |
| Interactions between uncoupling protein 2 gene polymorphisms, obesity and alcohol intake on liver function: a large meta-analysed population-based study. | Vimaleswaran KS et al. | — | 2015 | → |
| LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. | Bulik-Sullivan BK et al. | — | 2015 | → |
| Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. | Genetics of Personality Consortium et al. | — | 2015 | → |
| Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. | Freudenberg F et al. | — | 2015 | → |
| Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis. | Musliner KL et al. | — | 2015 | → |
| ReMo-SNPs: a new software tool for identification of polymorphisms in regions and motifs genome-wide. | Graae L et al. | — | 2015 | → |
| Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. | Samsom JN et al. | — | 2015 | → |
| The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects. | Peyrot WJ et al. | — | 2015 | → |
| A change in hippocampal protocadherin gamma expression in a learned helpless rat. | Garafola CS et al. | — | 2014 | → |
| Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder. | Kandaswamy R et al. | — | 2014 | → |
| Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. | Li M et al. | — | 2014 | → |
| Applying polygenic risk scores to postpartum depression. | Byrne EM et al. | — | 2014 | → |
| A recessive genetic model and runs of homozygosity in major depressive disorder. | Power RA et al. | — | 2014 | → |
| Association of HTR2A T102C and A-1438G polymorphisms with susceptibility to major depressive disorder: a meta-analysis. | Zhao X et al. | — | 2014 | → |
| Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. | Sprangers MA et al. | — | 2014 | → |
| Chipping away at major depressive disorder. | Rucker JJ et al. | — | 2014 | → |
| DNA methylation profiling in the thalamus and hippocampus of postnatal malnourished mice, including effects related to long-term potentiation. | Weng X et al. | — | 2014 | → |
| Early intervention following trauma may mitigate genetic risk for PTSD in civilians: a pilot prospective emergency department study. | Rothbaum BO et al. | — | 2014 | → |
| Early risk factors for adult bipolar disorder in adolescents with mood disorders: a 15-year follow-up of a community sample. | Päären A et al. | — | 2014 | → |
| Effect of polygenic risk scores on depression in childhood trauma. | Peyrot WJ et al. | — | 2014 | → |
| Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding. | Schott BH et al. | — | 2014 | → |
| Etiological heterogeneity of symptom dimensions of adolescent depression. | Chen J et al. | — | 2014 | → |
| Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation. | Bedson E et al. | — | 2014 | → |
| Further confirmation of the association between anxiety and CTNND2: replication in humans. | Nivard MG et al. | — | 2014 | → |
| Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders. | Ligthart L et al. | — | 2014 | → |
| Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy. | Schneider M et al. | — | 2014 | → |
| Genetic variation in CACNA1C affects neural processing in major depression. | Backes H et al. | — | 2014 | → |
| Genome-wide polygenic scoring for a 14-year long-term average depression phenotype. | Chang SC et al. | — | 2014 | → |
| Heritability and genomics of gene expression in peripheral blood. | Wright FA et al. | — | 2014 | → |
| Identifying genetic variants for heart rate variability in the acetylcholine pathway. | Riese H et al. | — | 2014 | → |
| Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing. | Opmeer EM et al. | — | 2014 | → |
| Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution. | Ferentinos P et al. | — | 2014 | → |
| MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese. | Guan F et al. | — | 2014 | → |
| Molecular genetic overlap in bipolar disorder, schizophrenia, and major depressive disorder. | Schulze TG et al. | — | 2014 | → |
| MORC1 exhibits cross-species differential methylation in association with early life stress as well as genome-wide association with MDD. | Nieratschker V et al. | — | 2014 | → |
| No evidence for the association between a polymorphism in the PCLO depression candidate gene with memory bias in remitted depressed patients and healthy individuals. | Vrijsen JN et al. | — | 2014 | → |
| Preferences regarding targeted education and risk assessment in people with a family history of major depressive disorder. | Quinn V et al. | — | 2014 | → |
| Premorbid risk factors for major depressive disorder: are they associated with early onset and recurrent course? | Wilson S et al. | — | 2014 | → |
| Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank. | Dean B et al. | — | 2014 | → |
| Research review: Polygenic methods and their application to psychiatric traits. | Wray NR et al. | — | 2014 | → |
| Social defeat as an animal model for depression. | Hollis F et al. | — | 2014 | → |
| The gender-specific association of EHD3 polymorphisms with major depressive disorder. | Wang L et al. | — | 2014 | → |
| The genetic interacting landscape of 63 candidate genes in Major Depressive Disorder: an explorative study. | Lekman M et al. | — | 2014 | → |
| The genetics of major depression. | Flint J et al. | — | 2014 | → |
| The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. | Berger SM et al. | — | 2014 | → |
| Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity. | Albert PR et al. | — | 2014 | → |
| Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. | Mostafavi S et al. | — | 2014 | → |
| ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder. | de Klerk OL et al. | — | 2013 | → |
| A genome-wide association study of depressive symptoms. | Hek K et al. | — | 2013 | → |
| A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction. | Deo AJ et al. | — | 2013 | → |
| A mega-analysis of genome-wide association studies for major depressive disorder. | Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium et al. | — | 2013 | → |
| Association at SYNE1 in both bipolar disorder and recurrent major depression. | Green EK et al. | — | 2013 | → |
| Considering trauma exposure in the context of genetics studies of posttraumatic stress disorder: a systematic review. | Digangi J et al. | — | 2013 | → |
| Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. | Kendler KS et al. | — | 2013 | → |
| Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene. | Seo S et al. | — | 2013 | → |
| Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder. | Power RA et al. | — | 2013 | → |
| Genome-wide association studies in psychiatry: what have we learned? | Collins AL et al. | — | 2013 | → |
| Influence of COMT val158met genotype on the depressed brain during emotional processing and working memory. | Opmeer EM et al. | — | 2013 | → |
| Integrative mouse and human mRNA studies using WGCNA nominates novel candidate genes involved in the pathogenesis of major depressive disorder. | Malki K et al. | — | 2013 | → |
| Modulatory effects of the piccolo genotype on emotional memory in health and depression. | Woudstra S et al. | — | 2013 | → |
| Neurogenetics of depression: a focus on reward processing and stress sensitivity. | Bogdan R et al. | — | 2013 | → |
| Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. | Steen VM et al. | — | 2013 | → |
| No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis. | Gyekis JP et al. | — | 2013 | → |
| Optimal methods for using posterior probabilities in association testing. | Liu K et al. | — | 2013 | → |
| Resequencing three candidate genes for major depressive disorder in a Dutch cohort. | Verbeek EC et al. | — | 2013 | → |
| Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. | Minelli A et al. | — | 2013 | → |
| The Adult Netherlands Twin Register: twenty-five years of survey and biological data collection. | Willemsen G et al. | — | 2013 | → |
| The current state of play on the molecular genetics of depression. | Cohen-Woods S et al. | — | 2013 | → |
| The genetic basis of depression. | Hodgson K et al. | — | 2013 | → |
| The genetics of alcohol dependence. | Rietschel M et al. | — | 2013 | → |
| The implications of genomics on the nursing care of adults with neuropsychiatric conditions. | Schutte DL et al. | — | 2013 | → |
| The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. | Samaan Z et al. | — | 2013 | → |
| A fine-mapping study of 7 top scoring genes from a GWAS for major depressive disorder. | Verbeek EC et al. | — | 2012 | → |
| Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample. | Degenhardt F et al. | — | 2012 | → |
| A study of the combined effects of the EHD3 and FREM3 genes in patients with major depressive disorder. | Shi C et al. | — | 2012 | → |
| Behavioral genetics of affective and anxiety disorders. | Domschke K et al. | — | 2012 | → |
| CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. | Bhat S et al. | — | 2012 | → |
| Copy number variation in subjects with major depressive disorder who attempted suicide. | Perlis RH et al. | — | 2012 | → |
| Different gene sets contribute to different symptom dimensions of depression and anxiety. | van Veen T et al. | — | 2012 | → |
| Dissecting the genetic heterogeneity of depression through age at onset. | Power RA et al. | — | 2012 | → |
| Enriched pathways for major depressive disorder identified from a genome-wide association study. | Kao CF et al. | — | 2012 | → |
| Estimating the genetic variance of major depressive disorder due to all single nucleotide polymorphisms. | Lubke GH et al. | — | 2012 | → |
| Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses. | Visscher PM et al. | — | 2012 | → |
| Evidence of differential allelic effects between adolescents and adults for plasma high-density lipoprotein. | Middelberg RP et al. | — | 2012 | → |
| Gene-environment interaction in major depression and antidepressant treatment response. | Keers R et al. | — | 2012 | → |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | — | 2012 | → |
| Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. | Wray NR et al. | — | 2012 | → |
| Genome-wide association uncovers shared genetic effects among personality traits and mood states. | Luciano M et al. | — | 2012 | → |
| High dimensional endophenotype ranking in the search for major depression risk genes. | Glahn DC et al. | — | 2012 | → |
| Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage-dependent calcium channels in psychiatric disorders. | Van Den Bossche MJ et al. | — | 2012 | → |
| Identifying genetic marker sets associated with phenotypes via an efficient adaptive score test. | Cai T et al. | — | 2012 | → |
| Maternal depression and child and adolescent depression symptoms: an exploratory test for moderation by CRHR1, FKBP5 and NR3C1 gene variants. | Lewis G et al. | — | 2012 | → |
| Meta-analysis of genome-wide association studies for personality. | de Moor MH et al. | — | 2012 | → |
| MK4MDD: a multi-level knowledge base and analysis platform for major depressive disorder. | Guo L et al. | — | 2012 | → |
| Molecular mechanism of active zone organization at vertebrate neuromuscular junctions. | Nishimune H | — | 2012 | → |
| Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. | Lee PH et al. | — | 2012 | → |
| PCLO gene: its role in vulnerability to major depressive disorder. | Minelli A et al. | — | 2012 | → |
| Piccolo genotype modulates neural correlates of emotion processing but not executive functioning. | Woudstra S et al. | — | 2012 | → |
| Presynaptic Active Zone Density during Development and Synaptic Plasticity. | Clarke GL et al. | — | 2012 | → |
| Significant association of estrogen receptor binding site variation with bipolar disorder in females. | Graae L et al. | — | 2012 | → |
| Stress-related depression: neuroendocrine, genetic, and therapeutical aspects. | Bosch OG et al. | — | 2012 | → |
| The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits. | Arias B et al. | — | 2012 | → |
| A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families. | Pergadia ML et al. | — | 2011 | → |
| A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. | Klok MD et al. | — | 2011 | → |
| A new lead from genetic studies in depressed siblings: assessing studies of chromosome 3. | Hamilton SP | — | 2011 | → |
| Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples. | Tesli M et al. | — | 2011 | → |
| Association study in eating disorders: TPH2 associates with anorexia nervosa and self-induced vomiting. | Slof-Op 't Landt MC et al. | — | 2011 | → |
| A system for performing high throughput assays of synaptic function. | Hempel CM et al. | — | 2011 | → |
| Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: Interaction with SSRIs. | Klok MD et al. | — | 2011 | → |
| Database of genetic studies of bipolar disorder. | Piletz JE et al. | — | 2011 | → |
| Four potential criteria for deciding when to use antidepressants or psychotherapy for unipolar depression: a literature review. | Sharpley CF et al. | — | 2011 | → |
| Gene expression and genetic variation data implicate PCLO in bipolar disorder. | Choi KH et al. | — | 2011 | → |
| Genes, environment, and individual differences in responding to treatment for depression. | Uher R | — | 2011 | → |
| Genetic risk profiles for depression and anxiety in adult and elderly cohorts. | Demirkan A et al. | — | 2011 | → |
| Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. | Middelberg RP et al. | — | 2011 | → |
| Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples. | Aragam N et al. | — | 2011 | → |
| Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. | Deelen J et al. | — | 2011 | → |
| Glucocorticoid receptor gene haplotype predicts increased risk of hospital admission for depressive disorders in the Helsinki birth cohort study. | Lahti J et al. | — | 2011 | → |
| Impact of changing drug treatment and malaria endemicity on the heritability of malaria phenotypes in a longitudinal family-based cohort study. | Loucoubar C et al. | — | 2011 | → |
| Influence of candidate genes on attention problems in children: a longitudinal study. | van Beijsterveldt CE et al. | — | 2011 | → |
| Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | Liu Y et al. | — | 2011 | → |
| Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. | Shyn SI et al. | — | 2011 | → |
| PCLO rs2522833 impacts HPA system activity in healthy young adults. | Kuehner C et al. | — | 2011 | → |
| PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder. | Schuhmacher A et al. | — | 2011 | → |
| Piccolo regulates the dynamic assembly of presynaptic F-actin. | Waites CL et al. | — | 2011 | → |
| Poor replication of candidate genes for major depressive disorder using genome-wide association data. | Bosker FJ et al. | — | 2011 | → |
| Prioritization and association analysis of murine-derived candidate genes in anxiety-spectrum disorders. | Hettema JM et al. | — | 2011 | → |
| Prioritization and evaluation of depression candidate genes by combining multidimensional data resources. | Kao CF et al. | — | 2011 | → |
| Research review: gene-environment interaction research in youth depression - a systematic review with recommendations for future research. | Dunn EC et al. | — | 2011 | → |
| Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. | Uher R et al. | — | 2011 | → |
| The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | Håvik B et al. | — | 2011 | → |
| The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data. | Middeldorp CM et al. | — | 2011 | → |
| The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes. | Claes S et al. | — | 2011 | → |
| The neuronal transporter gene SLC6A15 confers risk to major depression. | Kohli MA et al. | — | 2011 | → |
| TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. | Erhardt A et al. | — | 2011 | → |
| Advances in molecular genetics of panic disorder. | Maron E et al. | — | 2010 | → |
| A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. | Lind PA et al. | — | 2010 | → |
| Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes? | Middeldorp CM et al. | — | 2010 | → |
| A quality control algorithm for filtering SNPs in genome-wide association studies. | Pongpanich M et al. | — | 2010 | → |
| Association analysis of SIGMAR1 with major depressive disorder and SSRI response. | Kishi T et al. | — | 2010 | → |
| Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. | Kohli MA et al. | — | 2010 | → |
| Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. | Huang J et al. | — | 2010 | → |
| Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. | Glessner JT et al. | — | 2010 | → |
| Genetic linkage of region containing the CREB1 gene to depressive disorders in families with recurrent, early-onset, major depression: a re-analysis and confirmation of sex-specific effect. | Maher BS et al. | — | 2010 | → |
| Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. | Athanasiu L et al. | — | 2010 | → |
| Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. | Rietschel M et al. | — | 2010 | → |
| Genome-wide association scan of trait depression. | Terracciano A et al. | — | 2010 | → |
| Genome-wide association studies: a powerful tool for neurogenomics. | Cowperthwaite MC et al. | — | 2010 | → |
| Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. | Beekman M et al. | — | 2010 | → |
| Genome-wide association study of major recurrent depression in the U.K. population. | Lewis CM et al. | — | 2010 | → |
| Genome-wide association study of suicide attempts in mood disorder patients. | Perlis RH et al. | — | 2010 | → |
| Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. | Uher R et al. | — | 2010 | → |
| Genotyping sleep disorders patients. | Kripke DF et al. | — | 2010 | → |
| Is depression "evolutionary" or just "adaptive"? A comment. | Sharpley CF et al. | — | 2010 | → |
| Joining the dots: neurobiological links in a functional analysis of depression. | Sharpley CF et al. | — | 2010 | → |
| L-type calcium channels and psychiatric disorders: A brief review. | Casamassima F et al. | — | 2010 | → |
| miRNA genes and the brain: implications for psychiatric disorders. | Forero DA et al. | — | 2010 | → |
| Molecular biology and genetics in clinical chemistry and laboratory medicine. | Whitfield JB | — | 2010 | → |
| Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. | Dao DT et al. | — | 2010 | → |
| On the relative efficiency of using summary statistics versus individual-level data in meta-analysis. | Lin DY et al. | — | 2010 | → |
| Overexpression of piccolo C2A domain induces depression-like behavior in mice. | Furukawa-Hibi Y et al. | — | 2010 | → |
| Overview of the genetics of major depressive disorder. | Lohoff FW | — | 2010 | → |
| Phenotypic complexity, measurement bias, and poor phenotypic resolution contribute to the missing heritability problem in genetic association studies. | van der Sluis S et al. | — | 2010 | → |
| Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. | Ressler KJ et al. | — | 2010 | → |
| Stimulated gene expression profiles as a blood marker of major depressive disorder. | Spijker S et al. | — | 2010 | → |
| The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. | Green EK et al. | — | 2010 | → |
| The CRF system, stress, depression and anxiety-insights from human genetic studies. | Binder EB et al. | — | 2010 | → |
| The functional c.-2G>C variant of the mineralocorticoid receptor modulates blood pressure, renin, and aldosterone levels. | van Leeuwen N et al. | — | 2010 | → |
| The genetics of affective disorder and suicide. | McGuffin P et al. | — | 2010 | → |
| The genetics of major depression: moving beyond the monoamine hypothesis. | Shyn SI et al. | — | 2010 | → |
| The Netherlands Twin Register biobank: a resource for genetic epidemiological studies. | Willemsen G et al. | — | 2010 | → |
| The PCLO gene and depressive disorders: replication in a population-based study. | Hek K et al. | — | 2010 | → |
| The perceived and predicted implications of psychiatric genetic knowledge among persons with multiple cases of depression in the family. | Laegsgaard MM et al. | — | 2010 | → |
| Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. | Sprangers MA et al. | — | 2010 | → |
| A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. | Knight HM et al. | — | 2009 | → |
| A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation. | Estrada K et al. | — | 2009 | → |
| Application of pharmacogenomics to clinical problems in depression. | Oestergaard S et al. | — | 2009 | → |
| From age correction to genome-wide association. | Cohen-Woods S et al. | — | 2009 | → |
| Genome-wide association study of exercise behavior in Dutch and American adults. | De Moor MH et al. | — | 2009 | → |
| Genome-wide association study of smoking initiation and current smoking. | Vink JM et al. | — | 2009 | → |
| Joint reanalysis of 29 correlated SNPs supports the role of PCLO/Piccolo as a causal risk factor for major depressive disorder. | Bochdanovits Z et al. | — | 2009 | → |
| Linkage and association studies of anxiety disorders. | Hamilton SP | — | 2009 | → |
| Sequence variants in three loci influence monocyte counts and erythrocyte volume. | Ferreira MA et al. | — | 2009 | → |
| Stress and depression: preclinical research and clinical implications. | Bartolomucci A et al. | — | 2009 | → |
| The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. | Sprangers MA et al. | — | 2009 | → |
| The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies. | Rice NE et al. | — | 2009 | → |
| The role of genetic variation in the causation of mental illness: an evolution-informed framework. | Uher R | — | 2009 | → |